M-DAPAGLIFLOZIN
Analogs of M-DAPAGLIFLOZIN
Find cheaper analogs and generic equivalents for M-DAPAGLIFLOZIN.
Active Ingredient: DAPAGLIFLOZIN
Product Overview
About M-DAPAGLIFLOZIN
M-DAPAGLIFLOZIN is a prescription medication containing the active ingredient Dapagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor. It is used in the treatment of type 2 diabetes mellitus to improve glycemic control.
Key Benefits & Uses
- Improves glycemic control by reducing glucose reabsorption in the kidneys
- Helps to lower HbA1c levels and reduce the risk of major adverse cardiovascular events
- May also be used to reduce blood pressure and body weight in patients with type 2 diabetes
Active Ingredient & Action
Dapagliflozin works by inhibiting the SGLT2 receptor in the kidneys, which reduces the reabsorption of glucose back into the bloodstream. This leads to increased glucose excretion in the urine and a decrease in blood glucose levels.
Important Notes
M-DAPAGLIFLOZIN is not indicated for the treatment of type 1 diabetes or diabetic ketoacidosis. It is also not recommended for patients with severe kidney impairment or end-stage renal disease. Patients with a history of pancreatitis or pancreatic cancer should use this medication with caution. It is essential to follow a healthy diet and exercise regularly while taking M-DAPAGLIFLOZIN to achieve optimal results.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.